BPS IC

Related by string. BPIC * BPD . bpd . bps . BPs . bp . Bp . Bpd . Bps . BPER : joint venture TNK BP . giant BP PLC . Doug Suttles BP . BPS PAY FREQ SEMI . Doug Suttles BP PLC . BP PLC Exxon Mobil . BP Deepwater Horizon . BP Oil Spill / Icing . ICD . ICS . icing . ICs . iced . Iced . ICED : ics file format . integrated circuits ICs . Lipton Brisk Iced Tea . iced coffee . iced tea . Log ic . IC Insights . IC packaging * *

Related by context. All words. (Click for frequent words.) 70 esophageal reflux 69 prospective multicenter study 68 dyslipidaemia 68 urolithiasis 68 autonomic dysfunction 68 nasal polyposis 68 metastatic neuroendocrine tumors 67 Legg Calvé Perthes disease 67 euthyroid 67 neurosensory 67 urothelial cancer 67 colorectal adenoma 67 histologic findings 66 risk reducing salpingo 66 clinicopathologic 66 esophagogastric 66 platelet dysfunction 66 atherothrombotic 66 leiomyomas 66 reflux esophagitis 66 functional gastrointestinal disorders 66 ANCA associated 66 gastroduodenal 66 artery stenosis 66 atrophic gastritis 66 angiographically 66 bronchial hyperresponsiveness 66 clinico pathological 66 Heavy menstrual bleeding 66 extrapulmonary 66 gastroesophageal reflux GERD 66 primary hyperparathyroidism 66 CP CPPS 66 primary aldosteronism 66 esophageal gastric 65 uricase 65 IntroductionThe 65 cranial irradiation 65 Venous thromboembolism 65 CTEPH 65 diabetic polyneuropathy 65 somatostatin analog 65 chronic thromboembolic pulmonary 65 metaplasia 65 HeFH 65 chorioamnionitis 65 electrophysiologic 65 cystoid macular edema 65 retrospective cohort 65 T1DM 65 urothelial carcinoma 65 coagulation abnormalities 65 NSAID induced 65 OSAHS 65 idiopathic pulmonary arterial hypertension 65 ß blockers 65 clinicopathological 65 bicuspid aortic valves 65 hyperprolactinemia 65 SSc 65 gastric adenocarcinoma 65 histologically proven 64 hyperphenylalaninemia HPA due 64 somatization disorder 64 alfuzosin 64 venous thromboembolic disease 64 β blockers 64 pyridostigmine 64 SGPT 64 gonococcal 64 IPAH 64 Atherosclerotic 64 somatoform disorders 64 interstitial brachytherapy 64 clevidipine 64 IOP lowering 64 spondyloarthritis 64 FDG PET imaging 64 idiopathic pulmonary 64 abacavir Ziagen 64 enthesitis 64 adenomatous 64 sJIA 64 comorbid depression 64 histologic subtype 64 airway hyperresponsiveness 64 intracranial hemorrhage ICH 64 ALI ARDS 64 ABCB1 64 neurological manifestations 64 differential gene expression 64 neuropathologic 64 CIMZIA TM certolizumab pegol 64 urodynamic 64 PLMs 64 valvular heart disease 64 aortic atherosclerosis 64 femoral neck fracture 64 gene polymorphism 64 postoperative AF 64 urodynamic parameters 64 vulvovaginal atrophy 64 bronchoalveolar 64 mucosal inflammation 64 polyarticular 64 OAB symptoms 64 psychiatric comorbidities 64 chronic prostatitis chronic 64 mechanically ventilated patients 64 renoprotective 63 intact parathyroid hormone 63 hypercholesterolaemia 63 cerebral vasospasm 63 pyelonephritis 63 myocardial fibrosis 63 Heritability 63 Systemic Lupus Erythematosus SLE 63 cervicitis 63 aortic root replacement 63 antiemetics 63 interstitial fibrosis 63 Chemotherapy induced 63 hemodynamic variables 63 renal allograft 63 levodopa induced 63 PFPS 63 comorbid anxiety 63 pulmonary resection 63 idiopathic PAH 63 extrapyramidal symptoms 63 constipation OIC 63 GH deficiency 63 detrusor overactivity 63 carotid stenosis 63 haematologic 63 proliferative retinopathy 63 thrombocytopenic 63 atherothrombosis 63 Meta analyzes 63 anticholinergic agents 63 symptomatic intracranial 63 etiologic 63 cardiac repolarization 63 lacunar 63 nondiabetic patients 63 patientswith 63 sonographic diagnosis 63 deep venous thromboses 63 gastric cardia 63 knee osteoarthritis OA 63 symptomatic benign prostatic 63 liver histology 63 vesicoureteral reflux VUR 63 G6PD deficiency 63 immunocompetent 63 neurocognitive impairment 63 intratympanic 63 bone scintigraphy 63 bronchogenic carcinoma 63 radicular pain 63 chronic prostatitis 63 hepatorenal syndrome 63 prospectively enrolled 63 Oropharyngeal Candidiasis 63 AGHD 63 atherothrombotic disease 63 intestinal permeability 63 gastro esophageal reflux 63 Hypertrophic 63 HRQL 63 bronchoalveolar lavage BAL 63 cerebrovascular accidents 63 vasomotor 63 anterior temporal 63 hypercalciuria 63 idiopathic myelofibrosis 63 acute respiratory tract infections 63 intrahepatic 63 vesicoureteral reflux 63 oesophagitis 63 mutated K ras 63 neuritic 63 bronchopulmonary 63 atherosclerotic renal artery stenosis 63 pulmonary artery banding 63 chronic myocardial ischemia 63 tissue oxygenation 63 embolic stroke 63 symptomatic VTE 63 diabetes mellitus DM 63 intracranial stenosis 63 echocardiographic parameters 63 hemodialysis patients 63 von Willebrand 63 transcranial Doppler ultrasound 63 papillary renal cell carcinoma 63 QT Prolongation 63 LV ejection fraction 62 adrenalectomy 62 hepatic cirrhosis 62 descending thoracic 62 BPH LUTS 62 hyperhomocysteinemia 62 Lewy bodies DLB 62 NNT = 62 nonischemic 62 acromegalic patients 62 unresectable tumors 62 nonarteritic anterior ischemic optic 62 intraobserver 62 atherogenic dyslipidemia 62 treat benign prostatic 62 sonographic appearance 62 calculi 62 percutaneous vertebroplasty 62 postmenopausal osteoporotic women 62 hippocampal sclerosis 62 hyperresponsiveness 62 aminotransferase 62 serum PTH 62 corticosteroid induced 62 FluCAM arm 62 post thrombotic syndrome 62 hyperlipidaemia 62 HIV HCV coinfected 62 Diabetic nephropathy 62 tacrolimus ointment 62 timepoints 62 portal vein thrombosis 62 septal defects 62 cerebral microbleeds 62 endothelial activation 62 histological subtype 62 T1a 62 Acute Renal Failure 62 cryptogenic 62 everolimus eluting stents 62 voiding dysfunction 62 interobserver 62 metabolic dysfunction 62 arthropathy 62 Vascugel ® 62 Irritable Bowel Syndrome IBS 62 thromboembolic disease 62 radicular 62 HRCT 62 vitreous floaters 62 Adverse effects 62 renal scarring 62 valvular heart 62 benign neoplasms 62 hypoperfusion 62 microvascular dysfunction 62 #:#-# [031] 62 CC genotype 62 neuropsychological impairments 62 nonalcoholic steatohepatitis NASH 62 morphometric vertebral fractures 62 Lymphocytic 62 proctitis 62 lipid lowering agents 62 metastatic lymph nodes 62 Liver transplantation 62 nicardipine 62 seropositivity 62 biochemical abnormalities 62 anagrelide 62 Severe Primary IGFD 62 alpha1 antitrypsin deficiency 62 vasogenic edema 62 prostate cancer CaP 62 cystic fibrosis chronic pancreatitis 62 Mitomycin C 62 Sociodemographic 62 haemodynamic 62 dyspnoea 62 PCWP 62 parkinsonian 62 gluten sensitive enteropathy 62 percutaneous transluminal coronary angioplasty 62 ileal 62 primary dysmenorrhoea 62 CRVO 62 cerebral angiography 62 Postoperative complications 62 antimuscarinic 62 extra articular 62 osteoid osteoma 62 dose proportionality 62 pT2 62 parkinson disease 62 endobronchial 62 hematological parameters 62 Trandolapril 62 intracerebral 62 selective agonists 62 thymectomy 62 hyoscyamine 62 Catheter Associated 62 carotid artery stenosis 62 pericardial effusion 62 endoscopic ultrasonography 62 diabetic microvascular complications 62 BEXXAR Therapeutic Regimen 62 parasitemia 62 Symptom severity 62 AST ALT 62 arterial hypertension 62 pentoxifylline 62 NMDA antagonists 62 pulmonary hypertension PH 62 Intra arterial 62 Histopathological 62 antiepileptics 62 variceal bleeding 62 polymyalgia rheumatica 62 abnormal uterine bleeding 62 elevated IOP 62 murine model 62 eculizumab therapy 62 RRM1 62 anticholinergic medication 62 conduction velocity 62 chronic periodontitis 62 tracheal intubation 62 cholestasis 62 functional mitral regurgitation 62 mesangial 62 pain palliation 62 bronchial epithelial cells 62 polytherapy 62 Tasigna prolongs 61 bronchoalveolar lavage 61 Irritable bowel syndrome 61 carotid artery stenting CAS 61 Primary endpoints 61 inhaled corticosteroid therapy 61 aripiprazole Abilify 61 serum lipid levels 61 genotypic resistance 61 DEFLUX 61 microbiologically evaluable 61 Adjunctive 61 coronary stenosis 61 rheumatic diseases 61 sacral neuromodulation 61 distensibility 61 hepatic lesions 61 % CI #.#-#.# [008] 61 Chronic Prostatitis 61 inflammatory biomarkers 61 gastro oesophageal reflux 61 carotid plaque 61 nonmetastatic 61 NICE SUGAR 61 Cardio vascular 61 hypervolemic hyponatremia 61 fibroma 61 bivariate analysis 61 thyrotropin 61 radiographic findings 61 carcinomatosis 61 Adenomas 61 ductal adenocarcinoma 61 Nonspecific 61 digital subtraction angiography 61 occlusive disease 61 carotid plaques 61 oncologic outcomes 61 Pelvic Organ Prolapse 61 severe exacerbations 61 antiphospholipid syndrome 61 natriuresis 61 tibiofemoral 61 nodal metastasis 61 hepatic metastases 61 Plaquenil 61 Skin sterol 61 benign paroxysmal positional vertigo 61 overactive bladder syndrome 61 LV dysfunction 61 Atomoxetine 61 macrovascular events 61 etiologic factors 61 pleiotropic effects 61 leiomyoma 61 microcirculatory 61 asplenia 61 osteoporotic vertebral fractures 61 multicentric 61 symptomatic paroxysmal AF 61 Mestinon 61 hemodynamic measurements 61 quetiapine Seroquel 61 multivariable adjusted 61 probiotic supplementation 61 neurogenic bladder 61 oral anticoagulation 61 hypothalamic pituitary 61 carotid IMT 61 efalizumab 61 Helicobacter pylori eradication 61 treat brain aneurysms 61 Myelodysplastic syndromes MDS 61 cerebrovascular disorders 61 calcaneal fractures 61 osteopathic manipulative treatment 61 colorectal adenocarcinoma 61 pretransplant 61 randomized controlled trials RCTs 61 recurrent laryngeal nerve 61 Diabetic Neuropathy 61 iNO 61 tumor necrosis 61 RezularTM 61 micafungin 61 eNO 61 Surgical resection 61 thetreatment 61 oral prednisolone 61 Alequel 61 microscopic colitis 61 mitral annular 61 Helicobacter pylori infection 61 valve implantation 61 hyperlipidemic 61 renal cysts 61 chronic rhinosinusitis 61 Subgroup analyzes 61 vaso occlusive crisis 61 Urinary tract 61 macrolide antibiotic 61 gene polymorphisms 61 Ischemic 61 QVAR R 61 ischemic mitral regurgitation 61 Histologic 61 lens opacities 61 Preoperatively 61 sacral nerve stimulation 61 pharmacodynamic parameters 61 headache abdominal pain 61 myeloproliferative 61 acute myocardial ischemia 61 Sjögren syndrome 61 elevated LDH 61 constipation predominant IBS 61 relapsed MM 61 cerebral oxygenation 61 cortical atrophy 61 artery occlusion 61 pancreatic ductal 61 thromboprophylaxis 61 hypercoagulable 61 acute aortic dissection 61 bacterial prostatitis 61 dosage regimens 61 guideline concordant 61 genetic loci 61 imipramine Tofranil 61 ADPKD 61 ORTHO EVRA R 61 urothelial 61 murine models 61 kidney urologic 61 obstructive sleep 61 thyrotropin levels 61 vascular occlusion 61 transaminase elevations 61 Chronic lymphocytic leukemia 61 NMIBC 61 observational cohort study 61 alexithymia 61 receptor inhibitor 61 hepato 61 nasal obstruction 61 topically administered 61 fulminant hepatic failure 61 bifurcated lesions 61 bullous 61 LRTI 61 Hepatotoxicity 61 psoriatic arthritis PsA 61 RE LY trial 61 transthyretin amyloidosis 61 dysfunctional voiding 61 NMES 61 glomerular 61 DAS# CRP 61 histologically confirmed 61 Cognitive impairment 61 RE LY ® 61 plasma pharmacokinetics 61 Secondary efficacy endpoints 61 supratentorial 61 neurologic impairment 61 Carotid endarterectomy 61 reflux disease GERD 61 DVT PE 61 trastuzumab Herceptin ® 61 bladder carcinoma 61 diabetic gastroparesis 61 renal cortical 61 hypogonadotropic hypogonadism 61 macular edema secondary 61 elevated ALT 61 Acute coronary syndromes 61 venous malformations 61 recurrent glioblastoma multiforme 61 riociguat 61 hamartoma 61 intravenous tissue plasminogen 61 antiandrogens 61 mesenteric 61 carcinoids 61 Electroencephalography 61 overt nephropathy 61 arterial calcification 61 duplex ultrasonography 61 benign prostatic hypertrophy BPH 61 polycythemia vera essential thrombocythemia 61 tubular atrophy 61 HER2 expression 61 nephrolithiasis 61 AVAPRO 61 subscale scores 61 clotrimazole 61 posterolateral fusion 61 atrioventricular block 61 hepatocellular 61 epoetin alpha 61 prostate carcinomas 61 monogenic 61 hamartomas 61 trials RCTs 61 fosbretabulin 61 gastric carcinoma 61 chronic venous insufficiency 61 hyperalgesia 61 dyskinetic 61 invasive aspergillosis 61 hyperintense lesions 60 myelodysplastic myeloproliferative diseases 60 non valvular atrial 60 arthralgias 60 visceral metastases 60 hydronephrosis 60 nondemented 60 albumin excretion rate 60 anticoagulant warfarin 60 urinary incontinence UI 60 zoledronate 60 PROactive study 60 LHON 60 salmeterol fluticasone 60 fructose intolerance 60 ventricular myocardium 60 Hypercholesterolemia 60 SIADH 60 HBeAg negative 60 thromboembolic complications 60 LAB CGRP 60 paraneoplastic 60 nitrofurantoin 60 prostate carcinoma 60 rheumatic arthritis 60 poststroke 60 HIV seropositive 60 cisplatin gemcitabine 60 dual endothelin receptor antagonist 60 Multivariate logistic regression 60 polyposis 60 ultrastructural 60 PsA 60 multivariate analyzes 60 myomas 60 Cognitive behavioral 60 cytomegalovirus infection 60 intracerebral haemorrhage 60 candidemia 60 osteoarthritic 60 Histological 60 COPD exacerbation 60 leucopenia 60 latent celiac disease 60 Lubiprostone 60 atrioventricular 60 RoACTEMRA 60 Multivariate analysis 60 microangiopathy 60 Treatment Outcome 60 monoclonal gammopathy 60 vWD 60 methacholine challenge 60 Major depressive disorder 60 mesalamine granules 60 complement inhibitor eculizumab 60 Lactobacillus GG 60 bexarotene 60 nephron sparing surgery 60 Cerebrospinal fluid 60 multivariable analysis 60 Akathisia 60 hypercalcaemia 60 bronchoalveolar lavage fluid 60 NIDDM 60 tamoxifen Nolvadex ® 60 psychiatric outpatients 60 thyroid carcinoma 60 thrombotic complications 60 transvaginal sonography 60 intrapartum 60 Chronic Heart Failure 60 Phenylketonuria PKU 60 fluconazole resistant 60 Eisenmenger syndrome 60 ULORIC 60 Chronic pelvic 60 lung resection 60 glucocorticoid induced 60 bivariate analyzes 60 torsade de pointes 60 electroencephalographic 60 oropharyngeal 60 radiotherapy RT 60 Afatinib 60 prospectively stratified 60 Leydig cell 60 SGRQ 60 serum phosphate 60 Patient Registry 60 lichen planus 60 serum retinol 60 pimecrolimus cream 60 dosimetric 60 spontaneous bacterial peritonitis 60 endometrial hyperplasia 60 familial clustering 60 mucinous 60 AA Amyloidosis 60 Iron Deficiency Anemia 60 null responder 60 leukocyte counts 60 varus deformity 60 transesophageal 60 thrombocytosis 60 atherogenesis 60 Serum concentrations 60 neuropsychiatric symptoms 60 BoNTA 60 depressive symptomatology 60 osteoporotic compression fractures 60 vasoactive 60 nadolol 60 #q# deletion 60 thyroid dysfunction 60 bronchopulmonary dysplasia BPD 60 Captopril 60 pretreatment serum 60 biliary tract cancer 60 thrombophilia 60 sinus tachycardia 60 rheumatic disorders 60 ergot alkaloids 60 hepatic arterial 60 CIMZIA ™ 60 pulmonary infiltrates 60 prostaglandin analogues 60 antiarrhythmic drug 60 hypertension PAH 60 autologous SCT 60 affective psychosis 60 Hypertriglyceridemia 60 biliary stones 60 aspirin clopidogrel 60 abnormal liver enzymes 60 mediastinitis 60 anastomotic leak 60 hematologic parameters 60 corneal ectasia 60 CRF antagonists 60 pouchitis 60 erythropoietic 60 degenerative lumbar 60 Infusion Reactions Severe 60 Aortic stenosis 60 PAOD 60 colorectal carcinoma 60 superior mesenteric artery 60 oral antidiabetic medication 60 Renal Artery 60 left ventricular diastolic 60 de novo AML 60 BENICAR HCT 60 TRAS 60 glaucomatous 60 hematopoietic cancers 60 mediated inhibition 60 antiphospholipid antibodies 60 mitochondrial toxicity 60 Pharmacologic 60 antioxidant supplementation 60 EBUS FNA 60 #:#-# [033] 60 hepatocellular carcinomas 60 HER2 overexpression 60 COPD exacerbations 60 glomerular filtration 60 adenoidectomy 60 external beam radiotherapy 60 serum lactate 60 Rheumatoid 60 anastomotic leaks 60 anemia thrombocytopenia 60 Neoplasms 60 cinacalcet 60 interstitial pneumonia 60 Endocarditis 60 overactive bladder symptoms 60 NATRECOR ® 60 Thal Dex 60 urethral stricture 60 methotrexate monotherapy 60 cardioembolic stroke 60 antiproliferative effects 60 genes differentially expressed 60 cerebral ischemia 60 periprocedural MI 60 GI toxicity 60 leptin deficiency 60 percutaneous drainage 60 artery calcification 60 lumbosacral spine 60 myogenic cell 60 Hp2 2 60 tumor histology 60 Relapsing remitting MS 60 uterine abnormalities 60 baseline LDH 60 osteochondrosis 60 ACEIs 60 esophageal manometry 60 proteoglycan 60 WOMAC scores 60 mitral stenosis 60 plasma lipids 60 recurrent acute pancreatitis 60 transrectal ultrasound guided 60 Candida infection 60 Cardiotoxicity 60 cardiac perfusion 60 nonsteroidal antiinflammatory drugs 60 arthrosis 60 Spasticity 60 organ perfusion 60 bone metabolism 60 ExTRACT TIMI 60 colorectal liver metastases 60 Electrophysiological 60 Tolvaptan 60 aMCI precursor 60 genitourinary cancers 60 florbetaben 60 acamprosate calcium 60 cytogenic 60 recurrent venous thromboembolism 60 #:#-# [035] 60 adverse reactions ≥ 60 Tumor Response 60 Adrenergic 60 granulomatous 60 QVAR ® 60 RISPERDAL ® 60 CI -#.# 60 certolizumab 60 pelvic lymphadenectomy 60 aerosolized KL4 surfactant 60 intraperitoneally 60 SIBO 60 WOMAC pain 60 prognostic variables 60 hyperintensities 60 upper gastrointestinal GI 60 metastatic gastric 60 hyperuricaemia 60 NYHA functional class 60 Tigecycline 60 Phenylketonuria 60 recurrent DVT 60 thiazide diuretic 60 meta regression 60 hypothalamic amenorrhea 60 sleep apneas 60 Exacerbations 60 erythrocyte sedimentation rate 60 EURIDIS 60 interobserver reliability 60 collagenous colitis 60 graft occlusion 60 BSIs 60 prucalopride 60 ischemic cardiomyopathy 60 ductal carcinomas 60 Current Controlled Trials 60 intraoperative complications 60 Cardiopulmonary bypass 60 Papillary 60 resected pancreatic cancer 60 corifollitropin alfa 60 neutropaenia 60 cough dyspnea 60 varicoceles 60 #OHD 60 dimeglumine 60 -#.# ± [002] 60 INCB# [003] 60 adnexal mass 60 syncope fainting 60 clinically detectable 60 headache nasopharyngitis 60 intima media thickness 60 isolated systolic hypertension 60 corticosteroid dose 60 PPCM 60 Elevated serum 60 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 60 Uroxatral 60 PHPT 60 hyper IgE syndrome 60 diabetic retinopathy DR 60 Antiviral Therapy 60 appendiceal 60 gallium nitrate 60 chronic gastritis 60 Buerger Disease 60 acute postoperative 60 fasting plasma 60 adenotonsillectomy 60 symptomatic ischemic 60 somatic symptoms 60 acetabular dysplasia 60 reuptake inhibitor 60 postintervention 60 Diastolic Heart Failure 60 Neurofibromatosis type 60 bacterial vaginosis BV 60 Non Alcoholic Steatohepatitis 60 corneal thickness 60 diabetes dyslipidemia 60 acetabular fracture 60 leukocyte count 60 prostate carcinogenesis 60 vascular dysfunction 60 symptomatic DVT 60 nadroparin 60 neuropsychiatric diseases 60 micronutrient supplementation 60 gauge vitrectomy 60 Atopic 60 postoperative infections 60 idiopathic intracranial hypertension 60 lipodystrophy syndrome 60 Univariate analysis 60 tipranavir r 60 cerebral infarction 60 vasodilatation 60 Bacteremia 60 alveolar epithelial cells 60 renal tumors 60 TOVIAZ 60 postoperative delirium 60 clinicopathological features 60 prospectively evaluated 60 See WARNINGS 60 cardiomegaly 59 urologic diseases 59 genotype phenotype 59 genetic polymorphisms 59 #p#.# [002] 59 ureteric 59 tonsillar hypertrophy 59 aetiological 59 hemorrhagic cystitis 59 scintigraphic 59 Injury Severity Score 59 atherosclerotic vascular disease 59 steatohepatitis 59 Dysplasia 59 saline infusion 59 Efficacy endpoints 59 gallstone disease 59 microsatellite instability 59 oesophageal adenocarcinoma 59 ara C 59 APOE genotype 59 hyperplastic 59 invasive candidiasis 59 comorbid psychiatric disorders 59 efficacy evaluable 59 etiological 59 IDDM 59 ragweed allergic 59 myofascial pain syndrome 59 rebleeding 59 peritoneal fluid 59 Chronic Fatigue Syndrome CFS 59 aldosterone antagonists 59 subsyndromal 59 Bronchiectasis 59 paricalcitol 59 receptor antagonism 59 congenital deficiency 59 CLINICAL STUDIES 59 mania hypomania 59 stone formers 59 Juvenile Idiopathic Arthritis 59 Oesophageal 59 urine albumin 59 pancreatic ductal adenocarcinoma 59 REMINYL ® 59 N. gonorrhoeae 59 Teriflunomide 59 T2DM 59 macrovascular disease 59 endothelium dependent 59 astrocytomas 59 familial aggregation 59 abdominal pelvic 59 lipid parameters 59 Intravenous immunoglobulin 59 PLX STROKE targeting 59 observational cohort 59 osteochondromas 59 diastolic hypertension 59 subarachnoid hemorrhage SAH 59 insomnia somnolence 59 posttreatment 59 Arrhythmias 59 pituitary adenomas 59 Langerhans cell histiocytosis 59 cardiac malformations 59 hippocampal atrophy 59 hyperammonemia 59 paroxetine sertraline 59 TT genotype 59 longitudinal cohort study 59 chondral 59 Prostatitis 59 vascular reactivity 59 Postoperatively 59 LHRH receptor positive 59 syndromic 59 myocardial ischaemia 59 metastatic malignant 59 Atypical antipsychotics 59 skeletal metastases 59 pharmacologic treatments 59 enterococcal 59 atypical neuroleptics 59 Polymorphism 59 Exclusion criteria 59 endoscopic retrograde 59 AV fistulas 59 Hematologic 59 erythema nodosum 59 myocardial viability 59 triiodothyronine 59 pathophysiologic 59 ventilation perfusion 59 Deep venous thrombosis 59 flutamide 59 TEAEs 59 systemic JIA 59 microvessel 59 surgically resected 59 ureteral obstruction 59 obscure gastrointestinal bleeding 59 allergic eczema 59 delayed gastric emptying 59 liver metastasis 59 recurrent miscarriage 59 gastrointestinal dysfunction 59 hMG 59 immunosuppression therapy 59 SSRI citalopram 59 aromatase inhibitors AIs 59 dorsal root ganglion 59 undergoing coronary angiography 59 plasma adiponectin 59 Myocardial Infarction TIMI 59 COL#A# 59 preterm neonates 59 allergic airway inflammation 59 Acute Coronary Syndromes ACS 59 Main Outcome Measure 59 Prospective Randomized 59 cytopenia 59 macroalbuminuria 59 acute myocardial infarction MI

Back to home page